These insights not only contribute to our understanding of PDAC but also pave the way for targeted interventions aimed at harnessing the microbiota to optimize immunotherapeutic approaches in cancer, with particular emphasis on the PD-L1 pathway. The gene discussed is CD274; the disease is cancer.